InsidersTradesSigma
Lytix Biopharma ASA: management transactions · Norway · Oslo Børs
OSLO:lytix-biopharma-asaNO·Oslo BørsMcap 674M€Healthcare & Pharma
Browse the full management transaction log of Lytix Biopharma ASA, a listed issuer based in Norway. Shares are quoted on NO NO, under the authority of Oslo Børs. Operating in the Healthcare & Pharma sector, Lytix Biopharma ASA has published 15 insider filings. Market capitalisation: €674.4m. The latest transaction was disclosed on 9 April 2026 (Option grant). Among the most active insiders: Norwegian Securities Trading Act.. All data is accessible without an account.
15
Insider Decl.
0
Thresholds
€473,332
7 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
10.80 €
Income statement
Net income−60.0 M€
Balance sheet & cash
Market cap674.4 M€
Total debt2.2 M€
Free Cash Flow−59.9 M€
Last declaration on 9 April 2026
Declarations15 total
Executives●Purchase0Oslo
€8,47010,000 shares@ €0.847
ShareMERK
OSLO:661716·
Ideal exit: 7 Sept 2026 (T+270)
Executives●Subscription0Oslo
€322,457724,448 shares@ €0.4451
ShareMERK
OSLO:616907·
Executives●Purchase0Oslo
€28,68833,519 shares@ €0.8559
ShareMERK
OSLO:570389·
Ideal exit: 29 May 2023 (T+270)
Executives●Purchase0Oslo
€103,302125,000 shares@ €0.8264
ShareMERK
OSLO:569902·
Ideal exit: 24 May 2023 (T+270)
Executives●Purchase0Oslo
€10,41513,000 shares@ €0.8011
ShareMERK
OSLO:569869·
Ideal exit: 23 May 2023 (T+270)
15 of 15 declarations
